Phase I Clinical Trials Overview | Dana-Farber Cancer Institute
34:21
Phase I Clinical Trials: Objectives, Design, and Endpoints
35:40
Understanding BRCA 1/2 Cancer Risk | Dana-Farber Cancer Institute
1:29:48
IPPCR 2015: Overview of Clinical Study Design
25:33
Understanding Your Pathology Report | 2024 Ductal Carcinoma In Situ Patient Forum
31:53
Lecture 2 - Surrogate Endpoints in Oncology - Reading and Interpreting Cancer Trials
59:38
FDA Auditor Gives Priceless Clinical Trial Advice
1:31:06
The FDA Drug Development Process: GLP, GMP and GCP Regulations
1:01:14